North Rock Partners, LLC Bristol Myers Squibb CO Transaction History
North Rock Partners, LLC
- $4.99 Billion
- Q3 2025
A detailed history of North Rock Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, North Rock Partners, LLC holds 32,902 shares of BMY stock, worth $1.54 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
32,902
Previous 27,676
18.88%
Holding current value
$1.54 Million
Previous $1.28 Million
15.77%
% of portfolio
0.03%
Previous 0.04%
Shares
35 transactions
Others Institutions Holding BMY
# of Institutions
2,688Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...